News

Gastrointestinal Stromal Tumor Pipeline Strong With 25+ Companies Driving Therapeutic Innovation: Delveinsight
DelveInsight's, “Gastrointestinal Stromal Tumors Pipeline Insight 2025” report provides comprehensive insights about 25+ ...
Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead The Charge In Pioneering New Treatments Delveinsight
The bispecific antibody market is experiencing rapid growth, primarily driven by the increasing prevalence of complex chronic diseases, such as cance ...